Mycotopia Therapies, Inc.
TPIA · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $1 |
| % Growth | – | -100% | -99.7% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | 100% | 50% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $1 | $0 |
| SG&A Expenses | $0 | $0 | $1 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $0 | $0 | $1 | $0 |
| Operating Income | -$0 | -$0 | -$1 | -$0 |
| % Margin | – | – | -24,254% | -74.8% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | $0 |
| Pre-Tax Income | -$1 | -$0 | -$1 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$1 | -$0 | -$1 | -$0 |
| % Margin | – | – | -27,091% | -73.9% |
| EPS | -0.003 | 0.024 | -0.044 | -0.046 |
| % Growth | -111.2% | 154.8% | 3.9% | – |
| EPS Diluted | -0.003 | 0.024 | -0.044 | -0.046 |
| Weighted Avg Shares Out | 195 | 47 | 13 | 11 |
| Weighted Avg Shares Out Dil | 195 | 47 | 13 | 11 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$0 | -$0 | -$1 | -$0 |
| % Margin | – | – | -24,254% | -49.5% |